Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients

Kimberly G. Norman, Jeffrey A. Canter, Mingjian Shi, Ginger L. Milne, Jason D. Morrow, James E Sligh

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Transplant recipients have an elevated risk of skin cancer, with a 65- to 250-fold increase in squamous cell carcinoma. Usage of the immunosuppressant cyclosporine A (CsA) is associated with the development of skin cancer. We hypothesized that the increased incidence of skin cancer was due to the action of CsA within keratinocyte mitochondria where it can inhibit mitochondrial permeability transition pore (MPTP) opening. Normally, MPTP opening is induced by oxidative stress such as that caused by UV light and leads to cell death, thereby eliminating a cell that has been exposed to genotoxic insult. However, in the presence of CsA, damaged cells may survive and consequently form tumors. To test this hypothesis, we treated keratinocytes with levels of CsA used therapeutically in transplant patients and assessed their viability following UVA-irradiation. CsA prevented cell death by inhibiting MPTP opening, even though the levels of oxidative stress were increased markedly. Nim811, a non-immunosuppressive drug that can block the MPTP had a similar effect while the immunosuppressive drug tacrolimus that does not interact with the mitochondria had no effect. These findings suggest that CsA may promote skin cancer in transplant patients by allowing keratinocyte survival under conditions of increased genotoxic stress.

Original languageEnglish (US)
Pages (from-to)94-101
Number of pages8
JournalMitochondrion
Volume10
Issue number2
DOIs
StatePublished - Mar 2010
Externally publishedYes

Fingerprint

Skin Neoplasms
Keratinocytes
Cyclosporine
Cell Death
Transplants
Immunosuppressive Agents
Mitochondria
Oxidative Stress
Tacrolimus
Ultraviolet Rays
Pharmaceutical Preparations
DNA Damage
mitochondrial permeability transition pore
Transplant Recipients
Squamous Cell Carcinoma
Incidence
Neoplasms

Keywords

  • Cell death
  • Cyclosporine A
  • Organ transplantation
  • Oxidative stress
  • Skin cancer
  • UVA

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Molecular Medicine

Cite this

Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients. / Norman, Kimberly G.; Canter, Jeffrey A.; Shi, Mingjian; Milne, Ginger L.; Morrow, Jason D.; Sligh, James E.

In: Mitochondrion, Vol. 10, No. 2, 03.2010, p. 94-101.

Research output: Contribution to journalArticle

Norman, Kimberly G. ; Canter, Jeffrey A. ; Shi, Mingjian ; Milne, Ginger L. ; Morrow, Jason D. ; Sligh, James E. / Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients. In: Mitochondrion. 2010 ; Vol. 10, No. 2. pp. 94-101.
@article{766715b53c564305b9b668860909823c,
title = "Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients",
abstract = "Transplant recipients have an elevated risk of skin cancer, with a 65- to 250-fold increase in squamous cell carcinoma. Usage of the immunosuppressant cyclosporine A (CsA) is associated with the development of skin cancer. We hypothesized that the increased incidence of skin cancer was due to the action of CsA within keratinocyte mitochondria where it can inhibit mitochondrial permeability transition pore (MPTP) opening. Normally, MPTP opening is induced by oxidative stress such as that caused by UV light and leads to cell death, thereby eliminating a cell that has been exposed to genotoxic insult. However, in the presence of CsA, damaged cells may survive and consequently form tumors. To test this hypothesis, we treated keratinocytes with levels of CsA used therapeutically in transplant patients and assessed their viability following UVA-irradiation. CsA prevented cell death by inhibiting MPTP opening, even though the levels of oxidative stress were increased markedly. Nim811, a non-immunosuppressive drug that can block the MPTP had a similar effect while the immunosuppressive drug tacrolimus that does not interact with the mitochondria had no effect. These findings suggest that CsA may promote skin cancer in transplant patients by allowing keratinocyte survival under conditions of increased genotoxic stress.",
keywords = "Cell death, Cyclosporine A, Organ transplantation, Oxidative stress, Skin cancer, UVA",
author = "Norman, {Kimberly G.} and Canter, {Jeffrey A.} and Mingjian Shi and Milne, {Ginger L.} and Morrow, {Jason D.} and Sligh, {James E}",
year = "2010",
month = "3",
doi = "10.1016/j.mito.2009.10.001",
language = "English (US)",
volume = "10",
pages = "94--101",
journal = "Mitochondrion",
issn = "1567-7249",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients

AU - Norman, Kimberly G.

AU - Canter, Jeffrey A.

AU - Shi, Mingjian

AU - Milne, Ginger L.

AU - Morrow, Jason D.

AU - Sligh, James E

PY - 2010/3

Y1 - 2010/3

N2 - Transplant recipients have an elevated risk of skin cancer, with a 65- to 250-fold increase in squamous cell carcinoma. Usage of the immunosuppressant cyclosporine A (CsA) is associated with the development of skin cancer. We hypothesized that the increased incidence of skin cancer was due to the action of CsA within keratinocyte mitochondria where it can inhibit mitochondrial permeability transition pore (MPTP) opening. Normally, MPTP opening is induced by oxidative stress such as that caused by UV light and leads to cell death, thereby eliminating a cell that has been exposed to genotoxic insult. However, in the presence of CsA, damaged cells may survive and consequently form tumors. To test this hypothesis, we treated keratinocytes with levels of CsA used therapeutically in transplant patients and assessed their viability following UVA-irradiation. CsA prevented cell death by inhibiting MPTP opening, even though the levels of oxidative stress were increased markedly. Nim811, a non-immunosuppressive drug that can block the MPTP had a similar effect while the immunosuppressive drug tacrolimus that does not interact with the mitochondria had no effect. These findings suggest that CsA may promote skin cancer in transplant patients by allowing keratinocyte survival under conditions of increased genotoxic stress.

AB - Transplant recipients have an elevated risk of skin cancer, with a 65- to 250-fold increase in squamous cell carcinoma. Usage of the immunosuppressant cyclosporine A (CsA) is associated with the development of skin cancer. We hypothesized that the increased incidence of skin cancer was due to the action of CsA within keratinocyte mitochondria where it can inhibit mitochondrial permeability transition pore (MPTP) opening. Normally, MPTP opening is induced by oxidative stress such as that caused by UV light and leads to cell death, thereby eliminating a cell that has been exposed to genotoxic insult. However, in the presence of CsA, damaged cells may survive and consequently form tumors. To test this hypothesis, we treated keratinocytes with levels of CsA used therapeutically in transplant patients and assessed their viability following UVA-irradiation. CsA prevented cell death by inhibiting MPTP opening, even though the levels of oxidative stress were increased markedly. Nim811, a non-immunosuppressive drug that can block the MPTP had a similar effect while the immunosuppressive drug tacrolimus that does not interact with the mitochondria had no effect. These findings suggest that CsA may promote skin cancer in transplant patients by allowing keratinocyte survival under conditions of increased genotoxic stress.

KW - Cell death

KW - Cyclosporine A

KW - Organ transplantation

KW - Oxidative stress

KW - Skin cancer

KW - UVA

UR - http://www.scopus.com/inward/record.url?scp=76049119424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76049119424&partnerID=8YFLogxK

U2 - 10.1016/j.mito.2009.10.001

DO - 10.1016/j.mito.2009.10.001

M3 - Article

C2 - 19836469

AN - SCOPUS:76049119424

VL - 10

SP - 94

EP - 101

JO - Mitochondrion

JF - Mitochondrion

SN - 1567-7249

IS - 2

ER -